Advocating the potential for a single dose of #SARSCoV2 vaccines @zeynep @michaelmina_lab https://www.nytimes.com/2020/12/18/opinion/coronavirus-vaccine-doses.html?action=click&module=Opinion&pgtype=Homepage …
The points for studying this are good but the public message to many for skipping the 2nd dose is troubling when we don't really know what protection that provides
-
Show this thread
-
It is one thing to propose measures to colleagues, it is another thing to advocate publicly.
@michaelmina_lab stop grandstanding with 1/2 good ideas. Will people with limited immunity behave accordingly? We can’t agree on masks. This only obfuscates the message to the public.3 replies 0 retweets 2 likes
Big issue with masks was that we did not talk openly with the public. It's been the bane of our response. There is no "walled-off" colleagues, and grandstanding is unfair. And the trial is not half a good idea. Single dose was among the first questions FDA expert panel asked.
8:01 AM - 19 Dec 2020
0 replies
0 retweets
7 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.